{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:37:33Z","timestamp":1768315053341,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,27]]},"DOI":"10.1097\/qad.0b013e3283405c33","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T05:51:38Z","timestamp":1287813098000},"page":"2789-2796","source":"Crossref","is-referenced-by-count":27,"title":["Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals"],"prefix":"10.1097","volume":"24","author":[{"given":"Mark M","family":"Manak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry A","family":"Moshkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lequan T","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Meshki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin","family":"Tuluc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210130","first-page":"196","article-title":"Substance P and immunoregulation","volume":"46","author":"McGillis","year":"1987","journal-title":"Fed Proc"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.it.2009.03.006","article-title":"Neurokinin 1 receptor isoforms and the control of innate immunity","volume":"30","author":"Tuluc","year":"2009","journal-title":"Trends Immunol"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.94.8.4167","article-title":"A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei","volume":"94","author":"Kennedy","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1073\/pnas.0806632105","article-title":"Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor","volume":"105","author":"Lai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1517\/14656566.4.12.2279","article-title":"Aprepitant: a novel NK1-receptor antagonist","volume":"4","author":"Patel","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.71.10.7478-7487.1997","article-title":"Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype","volume":"71","author":"Bjorndal","year":"1997","journal-title":"J Virol"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.159.10.4952","article-title":"The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells","volume":"159","author":"Lieb","year":"1997","journal-title":"J Immunol"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1073\/pnas.071052298","article-title":"Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes","volume":"98","author":"Lai","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11481-006-9059-6","article-title":"Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro","volume":"2","author":"Wang","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11481-008-9117-3","article-title":"Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia\/macrophages","volume":"3","author":"Wang","year":"2008","journal-title":"J Neuroimmune Pharmacol"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-5728(96)00132-4","article-title":"Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages","volume":"71","author":"Ho","year":"1996","journal-title":"J Neuroimmunol"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/aid.2007.0207","article-title":"Elevated substance P levels in HIV-infected women in comparison to HIV-negative women","volume":"24","author":"Douglas","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/00002030-200110190-00019","article-title":"Elevated substance P levels in HIV-infected men","volume":"15","author":"Douglas","year":"2001","journal-title":"AIDS"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-5728(01)00439-8","article-title":"Substance P enhances HIV-1 replication in latently infected human immune cells","volume":"121","author":"Li","year":"2001","journal-title":"J Neuroimmunol"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1128\/JVI.78.6.2722-2728.2004","article-title":"In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists","volume":"78","author":"Stalmeijer","year":"2004","journal-title":"J Virol"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-5728(98)00173-8","article-title":"Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats","volume":"93","author":"Santoni","year":"1999","journal-title":"J Neuroimmunol"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/JCM.26.11.2371-2376.1988","article-title":"Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells","volume":"26","author":"Castro","year":"1988","journal-title":"J Clin Microbiol"},{"key":"R18-4-20210130","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1189\/jlb.0408260","article-title":"Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)","volume":"85","author":"Chernova","year":"2009","journal-title":"J Leukoc Biol"},{"key":"R20-4-20210130","first-page":"327","article-title":"New tetracarboxylate chelators for fluorescence measurement and photochemical manipulation of cytosolic free calcium concentrations","volume":"40","author":"Tsien","year":"1986","journal-title":"Soc Gen Physiol Ser"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(86)92808-4","article-title":"Administration of 3\u2032-azido-3\u2032-deoxythymidine, an inhibitor of HTLV-III\/LAV replication, to patients with AIDS or AIDS-related complex","volume":"1","author":"Yarchoan","year":"1986","journal-title":"Lancet"},{"key":"R22-4-20210130","first-page":"224","article-title":"Progress in drug therapies for HIV infection","volume":"103","author":"Broder","year":"1988","journal-title":"Public Health Rep"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.bjc.6690039","article-title":"Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors","volume":"79","author":"Palma","year":"1999","journal-title":"Br J Cancer"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-6997(25)06810-3","article-title":"Receptors and antagonists for substance P and related peptides","volume":"46","author":"Regoli","year":"1994","journal-title":"Pharmacol Rev"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.1021\/bi00162a019","article-title":"The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides","volume":"31","author":"Fong","year":"1992","journal-title":"Biochemistry"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003088-200544060-00005","article-title":"Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant","volume":"44","author":"Bergman","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1124\/dmd.104.000216","article-title":"Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant","volume":"32","author":"Sanchez","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2125.1997.00644.x","article-title":"Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir","volume":"44","author":"Eagling","year":"1997","journal-title":"Br J Clin Pharmacol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e3283405c33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:56:12Z","timestamp":1740628572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201011270-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,27]]},"references-count":28,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283405c33","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,27]]}}}